Skip to main content
letter
. 2020 Sep 30;93(1):32–34. doi: 10.1002/jmv.26016

Figure 1.

Figure 1

Panel A and B for each patients show evolution of lung disease at high‐resolution computerized tomography before and after subcutaneously tocilizumab